IRCT20180922041089N4已完成3 期
Evaluation of the effect of oral Ivermectin on the outcome of patients with COVID-19 and compare it with the effect of conucntional therapics in patients admitted to Ziaeian, Baharloo, Imam Khomeini in the spring and summer 2020
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Patients 18 to 50 years
- •Infected by the COVID 19 virus
- •Patients with clinical symptoms, history of exposure to the patient and a positive RT-PCR test for Covid 19 from A laboratory or characteristic signs on a CT scan of the chest) with mild to moderate clinical manifestations according to the National Early Warning Score (NEWS) (mild: 1-4 / moderate: 5-6)
- •Obtaining informed written consent consciously
排除标准
- •Severely ill and hospitalized in the intensive care unit
- •Patients who are unable to take oral medications
- •Patients with AST / ALT levels more than 5 times above normal
- •Pregnant patients
研究者
相似试验
招募中
3 期
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 PatientsIRCT20210213050344N1Shiraz University of Medical Sciences375
招募中
不适用
Efficacy of Ivermectin in the treatment of COVID-19IRCT20210901052358N4Shahid Beheshti University of Medical Sciences60
招募中
2 期
Effect of ivermectin in COVID-19IRCT20200329046892N3Rasht University of Medical Sciences60
招募中
3 期
Evaluation of the effect of ivermectin in intubated patients 19COVID-19, virus not identified.COVID-19, virus not identifiedU07.2IRCT20190417043295N2Ahvaz University of Medical Sciences40
招募中
2 期
Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20200408046987N2Akam Tejarat Fartak Farasoo150